Compare Ardor (ARDR) vs Enzyme (MLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ardor vs Enzyme — how do they compare? Ardor trades at Rp377.27 (market cap Rp480,7M, Rp15,19M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Ardor is far larger — about 3.6× Enzyme's market cap, and Ardor's supply is capped (998,5M / 998,5M ARDR (100%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Ardor for 21 Days and Enzyme for 29 Days on average.
| ARDR | MLN | |
|---|---|---|
Market Cap | Rp480,7M | Rp134,13M |
Volume (24h) | Rp15,19M | Rp104,56M |
Circulating Supply | 998,5M / 998,5M ARDR (100%) | 3,3M MLN |
Typical Hold Time | 21 Days | 29 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ardor (ARDR) shows limited market activity with a market cap of Rp480.7M and full circulating supply of 998.5 million tokens. The asset demonstrates complete token distribution with 100% circulation rate and relatively short average hold time of 21 days. Technical analysis indicates constrained trading activity with no significant price momentum observed in recent sessions.
Overall outlook remains cautious due to low market capitalization and limited trading volume. Key opportunities include potential ecosystem growth if network adoption increases, while major risks involve low liquidity and vulnerability to market volatility given the small market size.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
About Ardor
Ardor is a multichain blockchain platform designed with a parent-child chain architecture. The security of the entire network is upheld by the parent Ardor chain, while the interoperable child chains deliver full functionality. The team believes that this architecture, combined with hybrid user permissioning capabilities, provides the necessary flexibility for a wide range of use cases and facilitates the mainstream adoption of blockchain technology.
Read more on ARDR →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
